The p53 tumour suppressor is frequently inactivated in human tumours, One f
orm of inactivation results from overexpression of MDM2, that normally form
s a negative auto-regulatory loop with p53 and inhibits its activity throug
h complex formation, We have investigated whether disrupting the MDM2-p53 c
omplex in cells that overexpress MDM2 is sufficient to trigger p53 mediated
cell death. We find that expression of a peptide homologue of p53 that bin
ds to MDM2 leads to increased p53 levels and transcriptional activity. The
consequences are increased expression of the downstream effecters MDM2 and
p21(WAF1/CIP1), inhibition of colony formation, cell cycle arrest and cell
death. There is also a decrease in E2F activity, that might have been due t
o the known physical and functional interactions of MDM2 with E2F1/DP1, How
ever, this decrease is p53 dependent, as are also colony formation, cell cy
cle arrest and cell death, These results show that a peptide homologue of p
53 is sufficient to induce p53 dependent cell death in cells overexpressing
MDM2, and support the notion that disruption of the p53-MDM2 complex is a
target for the development of therapeutic agents.